CUAMC
China Universal Asset Management Company’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
17,904
+716
| +4% | +$4.59K | 0.01% | 354 |
|
|
2025
Q1 | $60.8K | Buy |
17,188
+2,653
| +18% | +$9.39K | 0.01% | 400 |
|
|
2024
Q4 | $54.9K | Buy |
14,535
+1,441
| +11% | +$5.45K | 0.01% | 446 |
|
|
2024
Q3 | $42.4K | Buy |
13,094
+5,104
| +64% | +$16.5K | ﹤0.01% | 394 |
|
|
2024
Q2 | $15.2K | Sell |
7,990
-5,014
| -39% | -$9.53K | ﹤0.01% | 396 |
|
|
2024
Q1 | $36.9K | Buy |
13,004
+5,189
| +66% | +$14.7K | ﹤0.01% | 421 |
|
|
2023
Q4 | $115K | Buy |
7,815
+6,085
| +352% | +$89.6K | 0.02% | 267 |
|
|
2023
Q3 | $31.7K | Buy |
1,730
+850
| +97% | +$15.6K | 0.01% | 262 |
|
|
2023
Q2 | $19K | Sell |
880
-17
| -2% | -$367 | 0.01% | 272 |
|
|
2023
Q1 | $26.3K | Buy |
897
+224
| +33% | +$6.57K | 0.01% | 196 |
|
|
2022
Q4 | $24.9K | Buy |
+673
| New | +$24.9K | 0.01% | 165 |
|